John J. Sperzel III - Feb 24, 2022 Form 4 Insider Report for T2 Biosystems, Inc. (TTOO)

Role
Chairman, Chief Executive Officer and President, Director
Signature
/s/ Michael Gibbs, Attorney-in-fact
Stock symbol
TTOO
Transactions as of
Feb 24, 2022
Transactions value $
-$63,532
Form type
4
Date filed
2/28/2022, 03:00 PM
Previous filing
Feb 23, 2022
Next filing
Apr 11, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TTOO Common Stock Options Exercise +333K 333K Feb 24, 2022 Direct F1
transaction TTOO Common Stock Tax liability -$63.5K -142K -42.47% $0.45 192K Feb 24, 2022 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TTOO Restricted Stock Units Options Exercise $0 -333K -33.33% $0.00 667K Feb 24, 2022 Common Stock 333K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F2 141,560 shares of common stock were automatically withheld at vesting to cover required tax withholding.
F3 On February 24, 2021 the reporting person was granted 1,000,000 RSU's that vest in three equal installments commencing on February 24, 2022.

Remarks:

Chairman, Chief Executive Officer and President